A new market study reveals a significant growth forecast for the global Epigenetics-Based Therapeutics Market The market, valued at USD 1.76 billion in 2024, is expected to reach USD 5.17 billion by 2032, demonstrating a Compound Annual Growth Rate (CAGR) of 14.40% during the forecast period. This remarkable expansion is driven by a deeper understanding of epigenetic mechanisms and th... http://https://in.linkedin.com/company/data-bridge-market-research